Weight change and blood coagulability and fibrinolysis in healthy obese women
- 1 February 2001
- journal article
- clinical trial
- Published by Springer Nature in International Journal of Obesity
- Vol. 25 (2), 212-218
- https://doi.org/10.1038/sj.ijo.0801540
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patientsThe Lancet, 1998
- Sustained improvement in blood lipids, coagulation, and fibrinolysis after major weight loss in obese subjectsEuropean Journal of Clinical Nutrition, 1998
- Plasminogen Activator Inhibitor–1, Tissue-Type Plasminogen Activator, and FibrinogenArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Body Weight and Mortality among WomenNew England Journal of Medicine, 1995
- Body Size and Fat Distribution as Predictors of Coronary Heart Disease among Middle-aged and Older US MenAmerican Journal of Epidemiology, 1995
- Increased insulin sensitivity and fibrinolytic capacity after dietary intervention in obese women with polycystic ovary syndromeMetabolism, 1995
- Impact of weight loss on plasminogen activator inhibitor (PAI-1), factor VII, and other hemostatic factors in moderately overweight adults.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Effect of weight loss on coagulation factors VII and XThe American Journal of Cardiology, 1989
- The effect of body build, diet and endocrine factors on the extrinsic fibrinolytic system in healthy young womenScandinavian Journal of Clinical and Laboratory Investigation, 1988
- Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations.BMJ, 1979